Human Genome Epidemiology Literature Finder
Records 1 - 9 (of 9 Records) |
Query Trace: Gastrointestinal Stromal Tumors and KRAS[original query] |
---|
Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1. Proceedings of the National Academy of Sciences of the United States of America 2012 Jul 109 (31): E2127-33. Ohashi Kadoaki, Sequist Lecia V, Arcila Maria E, Moran Teresa, Chmielecki Juliann, Lin Ya-Lun, Pan Yumei, Wang Lu, de Stanchina Elisa, Shien Kazuhiko, Aoe Keisuke, Toyooka Shinichi, Kiura Katsuyuki, Fernandez-Cuesta Lynnette, Fidias Panos, Yang James Chih-Hsin, Miller Vincent A, Riely Gregory J, Kris Mark G, Engelman Jeffrey A, Vnencak-Jones Cindy L, Dias-Santagata Dora, Ladanyi Marc, Pao Willi |
KRAS and BRAF mutations predict primary resistance to imatinib in gastrointestinal stromal tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Mar 18 (6): 1769-76. Miranda Claudia, Nucifora Martina, Molinari Francesca, Conca Elena, Anania Maria Chiara, Bordoni Andrea, Saletti Piercarlo, Mazzucchelli Luca, Pilotti Silvana, Pierotti Marco A, Tamborini Elena, Greco Angela, Frattini Mi |
No KRAS mutations found in gastrointestinal stromal tumors (GISTs): molecular genetic study of 514 cases. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2013 May . Lasota J, Xi L, Coates T, Dennis R, Evbuomwan MO, Wang ZF, Raffeld M, Miettinen M |
Molecular characterization of an Italian series of sporadic GISTs. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2013 Jan . Origone P, Gargiulo S, Mastracci L, Ballestrero A, Battistuzzi L, Casella C, Comandini D, Cusano R, Dei Tos AP, Fiocca R, Garuti A, Ghiorzo P, Martinuzzi C, Toffolatti L, Bianchi Scarrà G |
Kinase genotype analysis of gastric gastrointestinal stromal tumor cytology samples using targeted next-generation sequencing. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2015 Jan 13 (1): 202-6. Gleeson Ferga C, Kipp Benjamin R, Kerr Sarah E, Voss Jesse S, Graham Rondell P, Campion Michael B, Minot Douglas M, Tu Zheng J, Klee Eric W, Lazaridis Konstantinos N, Henry Michael R, Levy Michael |
Oncogene mutational analysis in Chinese gastrointestinal stromal tumor patients. OncoTargets and therapy 2018 11 2279-2286. Chen Qiong, Li Rong, Zhang Zhi-Gao, Deng Qiao-Ting, Li Kun, Wang Hao, Yang Xue-Xi, Wu Ying-So |
KIT-Dependent and KIT-Independent Genomic Heterogeneity of Resistance in Gastrointestinal Stromal Tumors - TORC1/2 Inhibition as Salvage Strategy. Molecular cancer therapeutics 2019 7 18 (11): 1985-1996. Mühlenberg Thomas, Ketzer Julia, Heinrich Michael C, Grunewald Susanne, Marino-Enriquez Adrian, Trautmann Marcel, Hartmann Wolfgang, Wardelmann Eva, Treckmann Jürgen, Worm Karl, Bertram Stefanie, Herold Thomas, Schildhaus Hans-Ulrich, Glimm Hanno, Stenzinger Albrecht, Brors Benedikt, Horak Peter, Hohenberger Peter, Fröhling Stefan, Fletcher Jonathan A, Bauer Sebasti |
Molecular Portrait of GISTs Associated With Clinicopathological Features: A Retrospective Study With Molecular Analysis by a Custom 9-Gene Targeted Next-Generation Sequencing Panel. Frontiers in genetics 2022 5 13 864499. Qian Haoran, Yan Na, Hu Xiaotong, Jiang Junchang, Cao Zhengzheng, Shen D |
[Molecular pathology of gastrointestinal neoplasms]. Magyar onkologia 2024 12 68 (4): 325. Tamás Strausz, László Báthory-Fülöp, Eszter Papp, Erika Tó |
- Page last reviewed:Feb 1, 2024
- Content source: